Mahsa Hassanipour

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Ischemia Reperfusion Injury

Hydrogen Peroxide

Tyrosine Kinase

Top Venues

Fundamental & clinical pharmacology

Clinical and experimental pharmacology & physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Elham Hakimizadeh, Saeedeh Tadayon, Mohammad Yassin Zamanian, Afsaneh Soltani, Lydia Giménez-Llort, Mahsa Hassanipour, Iman Fatemi
Gemfibrozil, a lipid-lowering drug, improves hepatorenal damages in a mouse model of aging. Fundamental & clinical pharmacology (2023)
Elham Hakimizadeh, Saeideh Tadayyonfar, Mohammad Yassin Zamanian, Afsaneh Soltani, Lydia Giménez-Llort, Mahsa Hassanipour, Iman Fatemi
Gemfibrozil, a lipid-lowering drug, improves hepatorenal damages in a mouse model of aging. Fundamental & clinical pharmacology (2023)
Maryam Zakeri, Iman Fatemi, Ayat Kaeidi, Mohammad Ali Zakeri, Elham Hakimizadeh, Mahsa Hassanipour, Mohammadreza Rahmani, Jalal Hassanshahi, Fatemeh Ayoobi, Mohammad Allahtavakoli
Pro-neurocognitive and anti-sarcopenic benefits of one-year metformin therapy in ovariectomized aged mice. Clinical and experimental pharmacology & physiology 46 (12) (2019)